Amyotrophic Lateral Sclerosis

PrimeC Shows Safety and Potential Benefit in ALS Phase 2b as FDA Authorizes Phase 3

Exploratory gains in function with a favorable safety profile led regulators to permit a larger, roughly 300-patient test.